Healthcare Market Update - December 2018
In our latest Healthcare Market Update we look at: Roivant’s continuing charge, AstraZeneca’s dealmaking, and one year on, the evolution of CAR-T therapies.
In our latest Healthcare Market Update we look at: Roivant’s continuing charge, AstraZeneca’s dealmaking, and one year on, the evolution of CAR-T therapies.